These non-promotional scientific presentations were presented at the medical congresses referenced below and are intended for U.S healthcare professionals who were in attendance for the purposes of scientific exchange.

These materials may contain information outside of the FDA approved label or relate to uses that have not been approved by the FDA. Syndax does not recommend use of Syndax products in any manner other than as described in the FDA-approved Prescribing Information.

American Society of Pediatric Hematology/Oncology Conference

Seattle, Washington Apr 3 - 6, 2024

Results 1

Abstract | Apr 3, 2024

2002 Pivotal Phase 2 Results of AUGMENT-101 for Revumenib in KMT2Ar Acute Leukemia: Pediatric Experience

Zwaan CM, et al.

View Material